Utility of phosphatidylethanol testing in liver transplant evaluation: examining concordance to self-reported alcohol use

Liver Transpl. 2023 Apr 1;29(4):456-458. doi: 10.1097/LVT.0000000000000097. Epub 2023 Feb 20.

Authors

Antú Segal^{1

2

3}, Elise Adkins¹, Megha Fatabhoy¹, Kelly Bryce^{1

2

3}, Humberto C Gonzalez^{2

3

4}, Lisa R Miller-Matero^{1

3

5}

Affiliations

¹ Behavioral Health Department, Detroit, Michigan, USA.
² Transplant Institute, Detroit, Michigan, USA.
³ Wayne State University School of Medicine, Detroit, Michigan, USA.
⁴ Department of Gastroenterology and Hepatology, Detroit, Michigan, USA.
⁵ Center for Health Policy and Health Services Research, Detroit, Michigan, USA.

PMID: 36799451
DOI: 10.1097/LVT.0000000000000097

No abstract available

MeSH terms

Alcohol Drinking / adverse effects
Alcohol Drinking / epidemiology
Biomarkers
Glycerophospholipids
Humans
Liver Transplantation* / adverse effects
Self Report

Substances

phosphatidylethanol
Glycerophospholipids
Biomarkers